Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ampio Pharmaceuticals
(NY:
AMPE
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EDT, Apr 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ampio Pharmaceuticals
< Previous
1
2
3
4
5
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 21, 2022
We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!
Via
InvestorPlace
Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket
September 21, 2022
Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday.
Via
Benzinga
ROSEN, A LONGSTANDING LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE
September 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket
September 14, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.
Via
Benzinga
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE
September 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket
September 08, 2022
Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
Via
Benzinga
NYSE:AMPE Investor Notice: Lawsuit Alleges Securities Laws Violations by Ampio Pharmaceuticals, Inc.
September 07, 2022
San Diego, CA -- (SBWIRE) -- 09/07/2022 -- An investor, who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE), filed a lawsuit over alleged violations of Federal Securities Laws by Ampio...
Via
SBWire
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
September 06, 2022
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Via
Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE
September 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session
September 02, 2022
Gainers
Via
Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
September 06, 2022
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 02, 2022
We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
September 02, 2022
Gainers
Via
Benzinga
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMPE
August 29, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)
August 26, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ampio Pharmaceuticals, Inc. (AMPE) Investors of Class Action and to Actively Participate
August 26, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)
August 24, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors
August 23, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors
August 22, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors
August 22, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
August 19, 2022
On Friday, 109 stocks hit new 52-week lows.
Via
Benzinga
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
August 19, 2022
From
The Schall Law Firm
Via
Business Wire
AMPIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
August 18, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors
August 18, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors
August 18, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Stockholder Alert: Robbins LLP Reminds Investors it Has Filed a Securities Fraud Lawsuit Against Ampio Pharmaceuticals, Inc.
August 18, 2022
From
Robbins LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors
August 18, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
August 18, 2022
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPE
August 18, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.